TY - JOUR
AU - 
TI - MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival
JF - Blood
DO - 10.1182/blood-2002-11-3507
DA - 2003-08-01
UR - https://www.deepdyve.com/lp/unpaywall/mek-erk-pathway-is-aberrantly-active-in-hodgkin-disease-a-signaling-Sxe6MiK6cp
DP - DeepDyve
ER -